X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.fiercepharma.com/pharma/gsk-scraps-plan-launch-oral-anemia-drug-eu-ceases-further-expansion
https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-gsks-anemia-drug-2023-02-01/
https://www.gsk.com/en-gb/media/press-releases/gsk-reports-outcome-from-us-fda-advisory-committee-meeting-on-daprodustat-for-anaemia-of-ckd/
https://endpts.com/fda-raises-safety-questions-with-gsks-potential-ckd-drug-ahead-of-adcomm/
https://pharmaphorum.com/news/gsks-daprodustat-will-face-fda-advisory-committee/#:~:text=GSK%20has%20said%20that%20its,the%20drug%20early%20next%20year
https://www.fiercepharma.com/pharma/after-roxadustat-vadadustat-snubs-glaxosmithklines-daprodustat-could-snag-class-first-us-nod
https://www.fiercebiotech.com/biotech/gsk-pulls-off-clean-sweep-endpoint-hits-anemia-phase-3-positioning-it-to-leapfrog
https://www.pharmatimes.com/news/positive_results_for_gsks_anaemia_drug_daprodustat_1383162
https://www.hl.co.uk/shares/stock-market-news/company--news/glaxosmithkline-clears-regulatory-hurdle-in-japan-for-duvroq
https://www.pharmaceutical-technology.com/news/gsk-duvroq-japan-approval/
https://www.biopharmadive.com/news/gsks-viiv-data-long-acting-two-drug-hiv/561494/
https://endpts.com/gsk-submits-its-first-application-for-daprodustat-in-japan-two-drugmakers-part-with-15m-to-avoid-opioid-trial/
https://www.fiercebiotech.com/biotech/chasing-astellas-and-mitsubishi-gsk-files-for-japanese-approval-oral-anemia-drug
https://seekingalpha.com/news/3402556-glaxos-daprodustat-par-amgens-aranesp-late-stage-study-japan
https://www.fiercebiotech.com/akebia-keryx-to-merge-creating-kidney-disease-specialist-ahead-showdown-fibrogen-glaxosmithkline
http://www.fiercebiotech.com/story/mitsubishi-tanabe-backs-akebia-phiii-350m-asian-deal-vadadustat/2015-12-14
Market Place
Share 
